Health Care & Life Sciences » Pharmaceuticals | Tianjin Ringpu Bio Technology Co. Ltd.

Tianjin Ringpu Bio Technology Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
749
582
789
958
1,031
1,173
Cost of Goods Sold (COGS) incl. D&A
313
250
343
430
515
644
Gross Income
436
332
446
527
516
529
SG&A Expense
296
314
319
366
405
390
EBIT
136
13
121
159
111
139
Unusual Expense
-
-
-
-
2
1
Non Operating Income/Expense
-
1
3
12
34
26
Interest Expense
2
2
5
10
16
18
Pretax Income
180
39
144
179
145
167
Income Tax
26
10
19
25
20
21
Equity in Affiliates
1
-
2
1
-
5
Consolidated Net Income
153
29
122
153
125
141
Net Income
152
27
110
133
105
119
Net Income After Extraordinaries
152
27
110
133
105
119
Net Income Available to Common
152
27
110
133
105
119
EPS (Basic)
0.39
0.07
0.28
0.34
0.26
0.29
Basic Shares Outstanding
386
388
389
394
404
404
EPS (Diluted)
0.39
0.07
0.28
0.34
0.26
0.29
Diluted Shares Outstanding
386
388
389
394
404
404
EBITDA
171
54
171
235
203
232
Other Operating Expense
4
4
7
2
-
-
Non-Operating Interest Income
18
9
11
8
17
20
Minority Interest Expense
1
2
12
21
20
22

About Tianjin Ringpu Bio Technology Co.

View Profile
Address
No. 1 Dongjiu Road
Tianjin Tianjin 300308
China
Employees -
Website http://www.ringpu.com
Updated 07/08/2019
Tianjin Ringpu Bio-technology Co., Ltd. engages in the provision of animal health services. Its business covers the research and development, production, sale, and technical services of veterinary medicine, veterinary biological products, veterinary preparations, and veterinary drug. The veterinary biological products include vaccines, therapeutic biological products, and diagnostic products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.